Add to ORKGIntroduction: Regional citrate anticoagulation (RCA) is gaining popularity in continous renal replacement therapy (CRRT) for critically ill patients. The risk of citrate toxicity is a primary concern during the prolonged process. The aim of this study was to assess the pharmacokinetics of citrate in critically ill patients with AKI, and used the kinetic parameters to predict the risk of citrate accumulation in this population group undergoing continuous veno-venous hemofiltration (CVVH) with RCA. Methods: Critically ill patients with AKI (n = 12) and healthy volunteers (n = 12) were investigated during infusin
Introduction: Regional citrate anticoagulation (RCA) is a valid option in patients at high risk of b...
BACKGROUND: Acute kidney injury (AKI) after liver transplantation (LT) is a frequent and serious co...
Purpose: Continuous renal replacement therapy (CRRT) is commonly used in the care of critically ill ...
Regional citrate anticoagulation (RCA) is gaining popularity in continous renal replacement therapy ...
Regional citrate anticoagulation (RCA) is gaining popularity in continous renal replacement therapy ...
Citrate regional anticoagulation in continuous renal replacement therapy (CRRT) is a relatively rece...
Objective: To investigate the efficacy and safety of regional citrate anticoagulation (RCA) in cont...
Abstract Background Regional anticoagulation with citrate is the recommended first line treatment fo...
Background: Heparins are used for circuit anticoagulation during continuous renal replacement therap...
Hemorrhagic complications have been reported in up to 30 % of critically ill patients with AKI under...
A systemic anticoagulation is often required to prevent circuit and filter clotting in ICU patients ...
<p>Plasma citrate concentrations (mean ± SD) during 120 min citrate infusion and 120 min after the e...
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critica...
Hemorrhagic complications have been reported in up to 30% of critically ill patients with AKI underg...
Background/Aims: Continuous renal replacement therapy (CRRT) is a treatment for acute kidney injury ...
Introduction: Regional citrate anticoagulation (RCA) is a valid option in patients at high risk of b...
BACKGROUND: Acute kidney injury (AKI) after liver transplantation (LT) is a frequent and serious co...
Purpose: Continuous renal replacement therapy (CRRT) is commonly used in the care of critically ill ...
Regional citrate anticoagulation (RCA) is gaining popularity in continous renal replacement therapy ...
Regional citrate anticoagulation (RCA) is gaining popularity in continous renal replacement therapy ...
Citrate regional anticoagulation in continuous renal replacement therapy (CRRT) is a relatively rece...
Objective: To investigate the efficacy and safety of regional citrate anticoagulation (RCA) in cont...
Abstract Background Regional anticoagulation with citrate is the recommended first line treatment fo...
Background: Heparins are used for circuit anticoagulation during continuous renal replacement therap...
Hemorrhagic complications have been reported in up to 30 % of critically ill patients with AKI under...
A systemic anticoagulation is often required to prevent circuit and filter clotting in ICU patients ...
<p>Plasma citrate concentrations (mean ± SD) during 120 min citrate infusion and 120 min after the e...
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critica...
Hemorrhagic complications have been reported in up to 30% of critically ill patients with AKI underg...
Background/Aims: Continuous renal replacement therapy (CRRT) is a treatment for acute kidney injury ...
Introduction: Regional citrate anticoagulation (RCA) is a valid option in patients at high risk of b...
BACKGROUND: Acute kidney injury (AKI) after liver transplantation (LT) is a frequent and serious co...
Purpose: Continuous renal replacement therapy (CRRT) is commonly used in the care of critically ill ...